Patents by Inventor Michael P. Draper

Michael P. Draper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230098554
    Abstract: Methods of treating or preventing a bacterial infection in a subject are disclosed herein, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon. Also disclosed is a pharmaceutical composition comprising the compound of the present invention for treating or preventing a bacterial infection in a subject, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon.
    Type: Application
    Filed: April 4, 2022
    Publication date: March 30, 2023
    Inventors: Michael P. Draper, S. Ken Tanaka
  • Publication number: 20210346408
    Abstract: The present invention provides methods of treating mycobacterial infections or mycobacterial diseases by administering a tetracycline compound, e.g., omadacycline, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 3, 2019
    Publication date: November 11, 2021
    Inventors: Michael Henry Cynamon, Michael P. Draper, Judith N. Steenbergen, S. Ken Tanaka
  • Patent number: 11129839
    Abstract: Methods of treating or preventing a bacterial infection in a subject are disclosed herein, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon. Also disclosed is a pharmaceutical composition comprising the compound of the present invention for treating or preventing a bacterial infection in a subject, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: September 28, 2021
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Michael P. Draper, S. Ken Tanaka
  • Publication number: 20200330489
    Abstract: Methods of treating or preventing a bacterial infection in a subject are disclosed herein, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon. Also disclosed is a pharmaceutical composition comprising the compound of the present invention for treating or preventing a bacterial infection in a subject, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon.
    Type: Application
    Filed: February 24, 2020
    Publication date: October 22, 2020
    Inventors: Michael P. Draper, S. Ken Tanaka
  • Publication number: 20200281948
    Abstract: Methods of treating or preventing a C. difficile infection and the associated pathological conditions related to C. difficile infection, are disclosed.
    Type: Application
    Filed: December 6, 2019
    Publication date: September 10, 2020
    Inventors: S. Ken Tanaka, Michael P. Draper
  • Publication number: 20190040001
    Abstract: A method for modulating RNA with tetracycline compounds is described.
    Type: Application
    Filed: February 20, 2018
    Publication date: February 7, 2019
    Inventors: Stuart B. Levy, Michael P. Draper, Mark L. Nelson, Graham Jones
  • Publication number: 20180133231
    Abstract: Methods of treating or preventing a bacterial infection in a subject are disclosed herein, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon. Also disclosed is a pharmaceutical composition comprising the compound of the present invention for treating or preventing a bacterial infection in a subject, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon.
    Type: Application
    Filed: September 22, 2017
    Publication date: May 17, 2018
    Inventors: Michael P. Draper, S. Ken Tanaka
  • Publication number: 20180016225
    Abstract: Methods and compounds for treating diseases with tetracycline compounds having a target therapeutic activity are described.
    Type: Application
    Filed: May 15, 2017
    Publication date: January 18, 2018
    Inventors: Stuart B. Levy, Michael P. Draper, Mark L. Nelson, Graham Jones
  • Publication number: 20170319603
    Abstract: Methods of treating or preventing a C. difficile infection and the associated pathological conditions related to C. difficile infection, are disclosed.
    Type: Application
    Filed: March 24, 2017
    Publication date: November 9, 2017
    Inventors: S. Ken Tanaka, Michael P. Draper
  • Patent number: 9562003
    Abstract: A method for modulating RNA with tetracycline compounds is described.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: February 7, 2017
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Stuart B. Levy, Michael P. Draper, Mark L. Nelson, Graham Jones
  • Patent number: 9481639
    Abstract: Methods and compositions for the treatment of skin disorders (e.g., acne, rosacea) are described.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: November 1, 2016
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Haregewein Assefa, Beena Bhatia, Michael P. Draper, Laura Honeyman, Oak K. Kim, Dennis P. Molnar
  • Publication number: 20150321997
    Abstract: A method for modulating RNA with tetracycline compounds is described.
    Type: Application
    Filed: July 2, 2015
    Publication date: November 12, 2015
    Applicant: PARATEK PHARMACEUTICALS, INC.
    Inventors: Stuart B. Levy, Michael P. Draper, Mark L. Nelson, Graham Jones
  • Publication number: 20150174144
    Abstract: Tetracycline compounds for treating neurodegenerative disorders are disclosed herein. Also disclosed is a pharmaceutical composition comprising the tetracycline compounds, and a method for treating, preventing, or ameliorating neurodegenerative disorders or inflammation in a subject by administering the tetracycline compounds or a pharmaceutical composition thereof, either alone or in combination with a second therapeutic agent.
    Type: Application
    Filed: July 15, 2013
    Publication date: June 25, 2015
    Inventors: Todd Bowser, Paul Higgins, Michael P. Draper, S. Ken Tanaka
  • Publication number: 20150141381
    Abstract: Methods and compounds for treating diseases with tetracycline compounds having a target therapeutic activity are described.
    Type: Application
    Filed: May 22, 2014
    Publication date: May 21, 2015
    Applicant: Paratek Pharmaceuticals, Inc.
    Inventors: Stuart B. Levy, Michael P. Draper, Mark L. Nelson, Graham Jones
  • Publication number: 20140343020
    Abstract: A method for modulating RNA with tetracycline compounds is described.
    Type: Application
    Filed: March 7, 2014
    Publication date: November 20, 2014
    Applicant: PARATEK PHARMACEUTICALS, INC
    Inventors: Stuart B. Levy, Michael P. Draper, Mark L. Nelson, Graham Jones
  • Publication number: 20130345179
    Abstract: Methods and compositions for the treatment of skin disorders (e.g., acne, rosacea) are described.
    Type: Application
    Filed: August 19, 2013
    Publication date: December 26, 2013
    Applicant: Paratek Pharmaceuticals, Inc.
    Inventors: Haregewein Assefa, Beena Bhatia, Michael P. Draper, Laura Honeyman, Oak K. Kim, Dennis P. Molnar
  • Patent number: 8513223
    Abstract: Methods and compositions for the treatment of skin disorders (e.g., acne, rosacea) are described.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: August 20, 2013
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Haregewein Assefa, Beena Bhatia, Michael P. Draper, Laura Honeyman, Oak Kim, Dennis P. Molnar
  • Patent number: 8399437
    Abstract: Methods for using tetracycline compounds for the treatment of spinal muscular atrophy are described.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: March 19, 2013
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Joel Berniac, Todd Bowser, Michael P. Draper, Stuart B. Levy, Mark L. Nelson
  • Publication number: 20110059962
    Abstract: Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of using substituted benzimidazole compounds, in, e.g., reducing virulence and infectivity, inhibiting biofilms and treating bacterial infections, are also provided.
    Type: Application
    Filed: April 22, 2010
    Publication date: March 10, 2011
    Inventors: MICHAEL N. ALEKSHUN, VICTORIA BARTLETT, MICHAEL P. DRAPER, LYNNE GARRITY-RYAN, RAINA GAY, MARK GRIER, OAK K. KIM, STUART B. LEVY